Le Lézard
Classified in: Health, Science and technology

Announcing Director of White House Office of National Drug Control Policy as Guest Speaker at Faces & Voices of Recovery's Recovery Leadership Summit


Dr. Gupta joins Johann Hari, Chacku Mathai, and Maia Szalavitz as speakers at this year's conference.

ST. PAUL, Minn., Oct. 1, 2022 /PRNewswire-PRWeb/ -- Faces & Voices of Recovery is pleased to announce Dr. Rahul Gupta as a guest speaker at the annual Recovery Leadership Summit, held this year in St. Paul, MN from October 2-5.

Rahul Gupta, MD, MPH, MBA, FACP, is the first medical doctor to serve as the Director of National Drug Control Policy and lead the Office of National Drug Control Policy (ONDCP), a component of the Executive Office of the President.

Dr. Gupta is a national and global thought leader and a driver of innovative public policies who practices what he preaches. He is a buprenorphine-waivered practitioner, providing medication-assisted treatment for people with opioid use disorder.

"Faces & Voices is honored to call Dr. Gupta an ally, advocate, and friend of the recovery movement. When leaders speak up to end stigma and fight for change, it benefits all communities, families, and people," says Phil Rutherford, Chief Operating Officer of Faces & Voices of Recovery.

The 2022 Recovery Leadership Summit will be held at RiverCentre on October 2-5. This annual conference of Recovery Leaders and Advocates is hosted by Faces & Voices of Recovery, the nation's leading recovery advocacy organization since 2001.

Donations to support Faces & Voices and the recovery community can be made online at https://facesandvoicesofrecovery.org/get-involved/donate/online-giving/. Charitable contributions support Faces & Voices of Recovery's efforts to eliminate the stigma of substance use disorders and make recovery possible for even more people.

Faces & Voices of Recovery is dedicated to organizing and mobilizing the over 23 million Americans in recovery from addiction to alcohol and other drugs. With the support of families, friends, and allies, recovery community organizations and networks are able to promote the right and resources to recover through advocacy, education, and demonstrating the power and proof of long-term recovery. For more information, visit http://www.facesandvoicesofrecovery.org.

Contact
Emily Porcelli
Marketing & Communications Manager
Faces & Voices of Recovery
202-737-0690
[email protected]

Media Contact

Emily Porcelli, Faces & Voices of Recovery, 1 202.741.9430, [email protected]

Patty McCarthy, Faces & Voices of Recovery, 2027370692, [email protected]

Facebook

 

SOURCE Faces & Voices of Recovery


These press releases may also interest you

at 08:00
CI&T Inc , a global digital specialist, announces today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (SEC). The report is available on the SEC's website,...

at 07:56
FlowFuse, a leading provider of the low-code end-to-end development platform for industrial applications, and Gallarus Industry Solutions Limited, the leading industry 4.0 integrator in Europe dedicated to digital transformation through the...

at 07:55
Aeterna Zentaris Inc. ("Aeterna") and Ceapro Inc. ("Ceapro") are pleased to announce that the Court of King's Bench of Alberta has issued a final order approving the arrangement described in the previously announced definitive agreement to combine...

at 07:45
HEALWELL AI achieved annual revenue from continuing operations of $7.32 million in fiscal 2023. HEALWELL ended 2023 with a strong balance sheet, having secured approximately $29.5 million from convertible debt and equity financings.Since its relaunch...

at 07:45
Magaya, the leading provider of logistics and supply chain automation software, is committing an additional multimillion-dollar...

at 07:35
Ironwood Pharmaceuticals, Inc. , a GI-focused healthcare company, today announced positive, primary results up to Day 91 for its Phase II exploratory STARGAZE trial evaluating apraglutide in patients with steroid-refractory gastrointestinal acute...



News published on and distributed by: